Literature DB >> 25503299

On the split personality of penultimate proline.

Matthew S Glover1, Liuqing Shi, Daniel R Fuller, Randy J Arnold, Predrag Radivojac, David E Clemmer.   

Abstract

The influence of the position of the amino acid proline in polypeptide sequences is examined by a combination of ion mobility spectrometry-mass spectrometry (IMS-MS), amino acid substitutions, and molecular modeling. The results suggest that when proline exists as the second residue from the N-terminus (i.e., penultimate proline), two families of conformers are formed. We demonstrate the existence of these families by a study of a series of truncated and mutated peptides derived from the 11-residue peptide Ser(1)-Pro(2)-Glu(3)-Leu(4)-Pro(5)-Ser(6)-Pro(7)-Gln(8)-Ala(9)-Glu(10)-Lys(11). We find that every peptide from this sequence with a penultimate proline residue has multiple conformations. Substitution of Ala for Pro residues indicates that multiple conformers arise from the cis-trans isomerization of Xaa(1)-Pro(2) peptide bonds as Xaa-Ala peptide bonds are unlikely to adopt the cis isomer, and examination of spectra from a library of 58 peptides indicates that ~80% of sequences show this effect. A simple mechanism suggesting that the barrier between the cis- and trans-proline forms is lowered because of low steric impedance is proposed. This observation may have interesting biological implications as well, and we note that a number of biologically active peptides have penultimate proline residues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25503299      PMCID: PMC4336576          DOI: 10.1007/s13361-014-1049-y

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  36 in total

1.  A database of 660 peptide ion cross sections: use of intrinsic size parameters for bona fide predictions of cross sections.

Authors:  S J Valentine; A E Counterman; D E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  1999-11       Impact factor: 3.109

2.  Cis peptide bonds in proteins: residues involved, their conformations, interactions and locations.

Authors:  D Pal; P Chakrabarti
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

3.  High-sensitivity ion mobility spectrometry/mass spectrometry using electrodynamic ion funnel interfaces.

Authors:  Keqi Tang; Alexandre A Shvartsburg; Hak-No Lee; David C Prior; Michael A Buschbach; Fumin Li; Aleksey V Tolmachev; Gordon A Anderson; Richard D Smith
Journal:  Anal Chem       Date:  2005-05-15       Impact factor: 6.986

4.  Three-dimensional ion mobility/TOFMS analysis of electrosprayed biomolecules.

Authors:  C S Hoaglund; S J Valentine; C R Sporleder; J P Reilly; D E Clemmer
Journal:  Anal Chem       Date:  1998-06-01       Impact factor: 6.986

5.  Cis-trans signatures of proline-containing tryptic peptides in the gas phase.

Authors:  Anne E Counterman; David E Clemmer
Journal:  Anal Chem       Date:  2002-05-01       Impact factor: 6.986

Review 6.  The tachykinin peptide family.

Authors:  Cinzia Severini; Giovanna Improta; Giuliana Falconieri-Erspamer; Severo Salvadori; Vittorio Erspamer
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

7.  Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel.

Authors:  Sarah C R Lummis; Darren L Beene; Lori W Lee; Henry A Lester; R William Broadhurst; Dennis A Dougherty
Journal:  Nature       Date:  2005-11-10       Impact factor: 49.962

8.  Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.

Authors:  Kristine N Brazin; Robert J Mallis; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

9.  Characterizing intermediates along the transition from polyproline I to polyproline II using ion mobility spectrometry-mass spectrometry.

Authors:  Liuqing Shi; Alison E Holliday; Huilin Shi; Feifei Zhu; Michael A Ewing; David H Russell; David E Clemmer
Journal:  J Am Chem Soc       Date:  2014-08-27       Impact factor: 15.419

10.  Side-chain effects on peptidyl-prolyl cis/trans isomerisation.

Authors:  U Reimer; G Scherer; M Drewello; S Kruber; M Schutkowski; G Fischer
Journal:  J Mol Biol       Date:  1998-06-05       Impact factor: 5.469

View more
  6 in total

1.  Multiple gas-phase conformations of proline-containing peptides: is it always cis/trans isomerization?

Authors:  Christopher B Lietz; Zhengwei Chen; Chang Yun Son; Xueqin Pang; Qiang Cui; Lingjun Li
Journal:  Analyst       Date:  2016-08-02       Impact factor: 4.616

2.  Cis→Trans Isomerization of Pro(7) in Oxytocin Regulates Zn(2+) Binding.

Authors:  Daniel R Fuller; Matthew S Glover; Nicholas A Pierson; DoYong Kim; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-06       Impact factor: 3.109

3.  Examining the Influence of Phosphorylation on Peptide Ion Structure by Ion Mobility Spectrometry-Mass Spectrometry.

Authors:  Matthew S Glover; Jonathan M Dilger; Matthew D Acton; Randy J Arnold; Predrag Radivojac; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-09       Impact factor: 3.109

4.  Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.

Authors:  Christopher R Conant; Daniel R Fuller; Tarick J El-Baba; Zhichao Zhang; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

5.  Substance P in the Gas Phase: Conformational Changes and Dissociations Induced by Collisional Activation in a Drift Tube.

Authors:  Christopher R Conant; Daniel R Fuller; Zhichao Zhang; Daniel W Woodall; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

6.  Sphaerostilbellins, New Antimicrobial Aminolipopeptide Peptaibiotics from Sphaerostilbella toxica.

Authors:  Bruno Perlatti; Connie B Nichols; J Andrew Alspaugh; James B Gloer; Gerald F Bills
Journal:  Biomolecules       Date:  2020-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.